Ranbaxy Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 14	Dec ' 12	Dec ' 11	Dec ' 10	Dec ' 09

Sources of funds

Owner's fund

Equity share capital

211.66

211.46

211.00

210.52

210.21

Share application money

0.50

1.11

0.67

6.60

175.85

Preference share capital

-

-

-

-

-

Reserves & surplus

884.83

1,709.51

1,713.16

4,915.28

3,748.54

Loan funds

Secured loans

1,011.75

944.18

229.59

195.39

175.83

Unsecured loans

4,979.31

3,819.43

3,653.82

4,065.33

3,172.55

Total

7,088.06

6,685.68

5,808.24

9,393.11

7,482.99

Uses of funds

Fixed assets

Gross block

3,337.81

3,118.22

2,886.15

2,857.63

2,620.92

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,325.67

1,124.69

1,019.15

1,145.52

1,027.52

Net block

2,012.13

1,993.53

1,867.00

1,712.12

1,593.41

Capital work-in-progress

183.63

159.60

209.12

330.18

414.92

Investments

4,080.88

3,131.17

3,410.79

3,804.44

3,833.69

Net current assets

Current assets, loans & advances

6,828.39

7,685.64

8,834.01

6,965.27

5,486.90

Less : current liabilities & provisions

6,016.98

6,284.25

8,512.68

3,418.90

3,845.92

Total net current assets

811.40

1,401.39

321.33

3,546.37

1,640.97

Miscellaneous expenses not written

-

-

-

-

-

Total

7,088.06

6,685.68

5,808.24

9,393.11

7,482.99

Notes:

Book value of unquoted investments

4,048.35

3,027.17

3,306.19

3,698.52

3,569.70

Market value of quoted investments

28.51

50.43

63.61

92.67

380.72

Contingent liabilities

1,222.20

789.63

927.85

276.13

261.05

Number of equity sharesoutstanding (Lacs)

4237.79

4229.14

4220.00

4210.41

4204.17